Superior Group of Companies (SGC) 10-K 13 Mar 24 2023 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2023	Feb. 27, 2024	Jun. 30, 2023
Document Information [Line Items]
Entity Central Index Key	0000095574
Entity Registrant Name	SUPERIOR GROUP OF COMPANIES, INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-05869
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	11-1385670
Entity Address, Address Line One	200 Central Avenue, Suite 2000
Entity Address, City or Town	St. Petersburg
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33701
City Area Code	727
Local Phone Number	397-9611
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SGC
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 107,200,000
Entity Common Stock, Shares Outstanding		16,709,591
Auditor Firm ID	248
Auditor Name	GRANT THORNTON LLP
Auditor Location	Tampa, Florida

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Net sales	$ 543,302	$ 578,831
Costs and expenses:
Cost of goods sold	339,755	385,472
Selling and administrative expenses	183,205	176,320
Goodwill impairment charge	0	45,918
Intangible assets impairment charge	0	5,581
Other periodic pension costs	855	2,116
Interest expense	9,718	4,894
Costs and Expenses, Excluding Gain on Sale of Property Plant and Equipment	533,533	620,301
Gain on sale of property, plant and equipment	0	3,435
Income (loss) before income tax expense	9,769	(38,035)
Income tax expense (benefit)	997	(6,065)
Net income (loss)	$ 8,772	$ (31,970)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.55	$ (2.03)
Diluted (in dollars per share)	$ 0.54	$ (2.03)
Weighted average shares outstanding during the period:
Weighted average number of shares outstanding during the period, basic (in shares)	15,968,199	15,764,859
Weighted average number of shares outstanding during the period, diluted (in shares)	16,159,308	15,764,859
Other comprehensive income (loss), net of tax:
Recognition of net losses included in net periodic pension costs	$ 163	$ 1,276
Current period gain (loss)	(172)	2,188
Loss on cash flow hedging activities	0	(47)
Foreign currency translation adjustment	735	(215)
Other comprehensive income	726	3,202
Comprehensive income (loss)	$ 9,498	$ (28,768)
Cash dividends per common share (in dollars per share)	$ 0.56	$ 0.54

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 19,896	$ 17,722
Accounts receivable, less allowance for doubtful accounts of $4,237 and $7,622, respectively	103,494	104,813
Accounts receivable - other	307	3,326
Inventories	98,067	124,976
Contract assets	48,715	52,980
Prepaid expenses and other current assets	8,881	14,166
Total current assets	279,360	317,983
Property, plant and equipment, net	46,890	51,392
Operating lease right-of-use assets	17,909	9,113
Deferred tax asset	12,356	10,718
Intangible assets, net	51,160	55,753
Other assets	14,775	11,982
Total assets	422,450	456,941
Current liabilities:
Accounts payable	50,520	42,060
Other current liabilities	43,978	38,646
Current portion of long-term debt	4,688	3,750
Current portion of acquisition-related contingent liabilities	1,403	736
Total current liabilities	100,589	85,192
Long-term debt	88,789	151,567
Long-term pension liability	13,284	12,864
Long-term acquisition-related contingent liabilities	557	2,245
Long-term operating lease liabilities	12,809	3,936
Other long-term liabilities	8,784	8,538
Total liabilities	224,812	264,342
Commitments and contingencies (Note 12)
Shareholders’ equity:
Preferred stock, $.001 par value - authorized 300,000 shares (none issued)	0	0
Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding - 16,564,712 and 16,376,683 shares, respectively	16	16
Additional paid-in capital	77,443	72,615
Retained earnings	122,464	122,979
Accumulated other comprehensive income (loss), net of tax:
Pensions	(1,122)	(1,113)
Foreign currency translation adjustment	(1,163)	(1,898)
Total shareholders’ equity	197,638	192,599
Total liabilities and shareholders’ equity	$ 422,450	$ 456,941

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accounts receivable, allowance for doubtful accounts	$ 4,237	$ 7,622
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	300,000	300,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	16,564,712	16,376,683
Common stock, shares outstanding (in shares)	16,564,712	16,376,683

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Performance Shares [Member] Common Stock [Member]	Performance Shares [Member] Additional Paid-in Capital [Member]	Performance Shares [Member] Retained Earnings [Member]	Performance Shares [Member] AOCI Attributable to Parent [Member]	Performance Shares [Member]	Restricted Stock [Member] Common Stock [Member]	Restricted Stock [Member] Additional Paid-in Capital [Member]	Restricted Stock [Member] Retained Earnings [Member]	Restricted Stock [Member] AOCI Attributable to Parent [Member]	Restricted Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2021																16,127,505
Balance at Dec. 31, 2021	$ 0	$ 0	$ (76)	$ 0	$ (76)											$ 16	$ 69,351	$ 163,836	$ (6,213)	$ 226,990
Common shares issued upon exercise of options and SARs, net (in shares)																80,434
Common shares issued upon exercise of options and SARs, net																$ 0	886	(158)	0	728
Performance based shares issued (in shares)						11,707					48,044
Performance based shares issued						$ 0	$ 0	$ 0	$ 0	$ 0
Restricted shares issued, net of forfeitures (in shares)						11,707					48,044
Restricted shares issued, net of forfeitures											$ 0	$ 0	$ 0	$ 0	$ 0
Restricted shares issued in conjunction with acquisition of business (in shares)											116,550
Restricted shares issued in conjunction with acquisition of business											$ 0	2,000	0	0	2,000
Share-based compensation expense																$ 0	4,289	0	0	4,289
Tax withheld on vesting of restricted shares and performance based shares (in shares)																(7,557)
Tax withheld on vesting of restricted shares and performance based shares																$ 0	(314)	0	0	(314)
Written put options																0	(3,597)	0	0	(3,597)
Cash dividends declared																0	0	(8,653)	0	(8,653)
Net income (loss)																0	0	(31,970)	0	(31,970)
Cash flow hedges, net of taxes																0	0	0	(47)	(47)
Pensions, net of taxes																0	0	0	3,464	3,464
Change in currency translation adjustment, net of taxes																$ 0	0	0	(215)	$ (215)
Balance (in shares) at Dec. 31, 2022																16,376,683				16,376,683
Balance at Dec. 31, 2022																$ 16	72,615	122,979	(3,011)	$ 192,599
Common shares issued upon exercise of options and SARs, net																0	274	(99)	0	175
Performance based shares issued (in shares)						2,981					155,213
Performance based shares issued						$ 0	$ 0	$ 0	$ 0	$ 0
Restricted shares issued, net of forfeitures (in shares)						2,981					155,213
Restricted shares issued, net of forfeitures											$ 0	$ 0	$ 0	$ 0	$ 0
Share-based compensation expense																0	3,787	0	0	3,787
Written put options																0	767	0	0	767
Cash dividends declared																0	0	(9,188)	0	(9,188)
Net income (loss)																0	0	8,772	0	8,772
Pensions, net of taxes																0	0	0	(9)	(9)
Change in currency translation adjustment, net of taxes																$ 0	0	0	735	$ 735
Common shares issued upon exercise of options and SARs, net (in shares)																29,835				28,728
Balance (in shares) at Dec. 31, 2023																16,564,712				16,564,712
Balance at Dec. 31, 2023																$ 16	$ 77,443	$ 122,464	$ (2,285)	$ 197,638

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash dividends declared, per share (in dollars per share)	$ 0.56	$ 0.54
Cash flow hedges, tax		$ 6
Pensions, tax	$ 3	1,281
Change in currency translation adjustment, tax	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 8,772	$ (31,970)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	13,995	13,004
Goodwill impairment charge	0	45,918
Intangible assets impairment charge	0	5,581
Inventory write-downs	2,346	13,569
Provision for bad debts - accounts receivable	539	2,891
Share-based compensation expense	3,787	4,289
Deferred income tax benefit	(1,635)	(12,352)
Gain on sale of property, plant and equipment	0	(3,435)
Change in fair value of acquisition-related contingent liabilities	(189)	(450)
Change in fair value of written put options	489	(1,565)
Changes in assets and liabilities, net of acquisition of businesses:
Accounts receivable	1,051	680
Accounts receivable - other	3,019	1,347
Contract assets	4,310	(15,092)
Inventories	24,672	(15,898)
Prepaid expenses and other current assets	5,496	5,225
Other assets	(2,012)	1,858
Accounts payable and other current liabilities	13,310	(14,614)
Payment of acquisition-related contingent liabilities	(279)	(3,346)
Long-term pension liability	407	2,190
Other long-term liabilities	851	(434)
Net cash provided by (used in) operating activities	78,929	(2,604)
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment	(4,963)	(11,018)
Proceeds from disposals of property, plant and equipment	0	4,795
Acquisition of businesses	0	(11,202)
Other investments	(545)	0
Net cash used in investing activities	(5,508)	(17,425)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from borrowings of debt	6,000	332,143
Repayment of debt	(67,750)	(292,773)
Debt issuance costs	(300)	(869)
Payment of cash dividends	(9,188)	(8,653)
Payment of acquisition-related contingent liabilities	(553)	(1,416)
Proceeds received on exercise of stock options	175	728
Tax withholdings on vesting of restricted shares and performance based shares and on exercise of stock rights	0	(314)
Net cash provided by (used in) financing activities	(71,616)	28,846
Effect of currency exchange rates on cash	369	(30)
Net increase in cash and cash equivalents	2,174	8,787
Cash and cash equivalents balance, beginning of year	17,722	8,935
Cash and cash equivalents balance, end of year	19,896	17,722
Supplemental disclosure of cash flow information:
Income taxes paid (refunded), net	(978)
Income taxes paid (refunded), net		1,348
Interest paid	$ 9,588	$ 4,767

Note 1 - Description of Busines

Note 1 - Description of Business, Basis of Presentation and Summary of Accounting Policies	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1 Description of business Superior Group of Companies, Inc. (together with its subsidiaries, “the Company,” “Superior,” “we,” “our,” or “us”) was organized in 1920 1922 1998, May 3, 2018, Superior’s Branded Products segment, primarily through its signature marketing brands BAMKO® and HPI®, produces and sells customized merchandising solutions, promotional products and branded uniform programs. Branded products are manufactured through third Superior’s Healthcare Apparel segment, primarily through its signature marketing brands Fashion Seal Healthcare®, Wink™ and CID Resources, manufactures (through third Superior’s Contact Centers segment, through multiple The Office Gurus® entities, including subsidiaries in El Salvador, Belize, Jamaica, Dominican Republic and the United States (collectively, “TOG”), provides outsourced, nearshore business process outsourcing, contact and call-center support services to North American customers. Basis of presentation The accompanying consolidated financial statements of Superior included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) (“U.S.” or “United States”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company refers to the consolidated financial statements collectively as “financial statements,” and individually as “statements of comprehensive income (loss),” “balance sheets,” “statements of shareholders’ equity,” and “statements of cash flows” herein. Reportable Segments Beginning in the second 2022, not no Note 6 Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses, as well as the disclosures of contingent assets and liabilities. Because of the inherent uncertainties in this process, actual future results could differ from those expected at the reporting date. Cash and cash equivalents The Company considers all highly liquid investments with an original maturity of three Revenue recognition Revenue is recognized when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. See Note 15 Accounts receivable and allowance for doubtful accounts Judgments and estimates are used in determining the collectability of accounts receivable and in establishing allowances for doubtful accounts. The Company analyzes specific accounts receivable and historical bad debt experience, customer credit worthiness, current economic trends and the age of outstanding balances when evaluating the adequacy of the allowance for doubtful accounts. Changes in estimates are reflected in the period they become known. Charge-offs of accounts receivable are made once all collection efforts have been exhausted. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may Cost of goods sold and shipping and handling fees and costs Cost of goods sold for our Branded Products segment and our Healthcare Apparel segment consist primarily of direct costs of acquiring inventory, including cost of merchandise, inbound freight charges, purchasing, receiving and inspection costs. Cost of goods sold for our Contact Centers segment includes salaries and payroll related benefits for agents. The Company includes shipping and handling fees billed to customers in net sales. Shipping and handling costs associated with out-bound freight are recorded in cost of goods sold. The cost of occupancy and operating the Company’s distribution centers are included in selling and administrative expenses. Inventories Inventories are stated at the lower of cost ( first first may Property, plant and equipment Property, plant and equipment are stated at cost, less accumulated depreciation. Major renewals and improvements are capitalized, while replacements, maintenance and repairs which do not 31, 2022, Property, plant and equipment is recorded at cost and depreciated using the straight-line method over its estimated useful life as follows: Buildings (in years) 20 to 40 Improvements (in years) 5 to 40 Machinery, equipment and fixtures (in years) 3 to 10 Leasehold improvements are depreciated over the terms of the leases to the extent that such improvements have useful lives of at least the terms of the respective leases. Impairment of long-lived assets Long-lived assets, such as property and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not no December 31, 2023 2022 Goodwill and indefinite-lived intangible assets The Company has made acquisitions in the past that included goodwill and indefinite-lived intangible assets. Goodwill represents the excess of the cost of an acquisition over the fair value of the net assets acquired. Goodwill and indefinite-lived intangible assets such as trade names are not fourth may not • macroeconomic conditions such as deterioration in general economic conditions, limitations on accessing capital, or other developments in equity and credit markets; • industry and market considerations such as a deterioration in the environment in which the Company operates, an increased competitive environment, a decline in market-dependent multiples or metrics (considered in both absolute terms and relative to peers), a change in the market for the Company’s products or services, or a regulatory or political development; • cost factors such as increases in raw materials, labor, or other costs that have a negative effect on earnings and cash flows; • overall financial performance such as negative or declining cash flows or a decline in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods; and • other relevant entity-specific events such as changes in management, key personnel, strategy, or customers. An entity has the option to first not 50% not not three In conjunction with the re-segmentation during the second 2022, third 2022, December 31, 2022. December 31, 2022, no In conjunction with the Company’s realignment of its reportable segments during the second 2022, no December 31, 2022. For the year ended December 31, 2023, December 31, 2023 2022 Contingent Consideration Contingent consideration relating to consideration transferred in exchange for an acquired business is recognized at its estimated fair value at the acquisition date. The contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved. Recognition of any changes in fair value are included in selling and administrative expenses in our statements of comprehensive income (loss). SERP The Company is the sponsor of an unfunded supplemental executive retirement plan (“SERP”) which includes one Insurance The Company self-insures for certain obligations related to employee health programs. The Company also purchases stop-loss insurance policies to protect it from catastrophic losses. Judgments and estimates are used in determining the potential value associated with reported claims and for losses that have occurred, but have not may Taxes on income Income taxes are provided for under the asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not not Note 9 Share-based compensation The Company awards share-based compensation as an incentive for employees to contribute to the Company’s long-term success. The Company grants options, stock-settled stock appreciation rights, restricted stock and performance shares. The Company recognizes share-based compensation expense for all awards granted to employees, which is based on the fair value of the award on the date of grant. Determining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s common stock price volatility, risk free interest rate and dividend rate. The assumptions used in calculating the fair value of stock compensation awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary to use different assumptions, stock compensation expense could be materially different from what has been recorded in the current period. Other comprehensive income (loss) Comprehensive income (loss) includes net income (loss) and all other changes in equity during a period except those resulting from investments by or distributions to shareholders. Other comprehensive income (loss) consists of defined benefit pension plans activities, cash flow hedging activities and foreign currency translation adjustment. The related tax effects of these items are recorded in income tax expense (benefit) within the statements of comprehensive income (loss), upon reclassification from accumulated other comprehensive income (loss), net of tax. Foreign Currency Translations and Transactions Assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the current rate of exchange on the last day of the reporting period. Changes in the carrying values of these assets and liabilities attributable to fluctuations in spot rates are recognized in net foreign currency translation adjustment, a component of accumulated other comprehensive income (loss), net of tax. Monetary assets and liabilities denominated in a currency that is different from a reporting entity’s functional currency are remeasured from the applicable currency to the reporting entity’s functional currency. Gains or losses resulting from transactions denominated in other currencies are recognized in net income (loss) each period. The majority of the Company’s transactions are settled in U.S. dollars. Risks and concentrations Financial instruments that potentially subject the Company to concentrations of credit risk include cash in banks in excess of federally insured amounts. The Company manages this risk by maintaining all deposits in high quality financial institutions and periodically performing evaluations of the relative credit standing of the financial institutions. When assessing credit risk the Company considers whether the credit risk exists at both the individual and group level. Consideration is given to the activity, region and economic characteristics when assessing if there exists a group concentration risk. At December 31, 2023 2022 no 10 December 31, 2023 2022 five none 10% 2023 no 10% 2023 Principal raw materials used to manufacture the Company’s finished goods include cotton, polyester, spandex, cotton-synthetic, poly-synthetic blends, textiles, plastic, glass, fabric and metal. The majority of such fabrics are sourced in China, either directly by us or our suppliers. If we are unable to continue to obtain our raw materials and finished products from China or if our suppliers are unable to source raw materials from China, it could significantly disrupt our business. Further, the Company and the Company’s suppliers generally source or manufacture finished goods in parts of the world that may Written Put Options During the second 2022, twenty-four December 31, 2023 480, December 31, 2023 2022 31, 2023 2022 December 31, 2023 Fair value of financial instruments The carrying amounts of cash and cash equivalents, receivables and accounts payable approximated fair value as of December 31, 2023 2022 Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not not Recently Issued Accounting Pronouncements Not In November 2023, 2023 07, "Segment Reporting (Topic 280 December 15, 2023, December 15, 2024. not In December 2023, 2023 09, "Income Taxes (Topic 740 December 15, 2024. not not

Note 2 - Allowance for Doubtful

Note 2 - Allowance for Doubtful Accounts Receivable	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 2 The activity in the allowance for doubtful accounts receivable was as follows (in thousands): Years Ended December 31, 2023 2022 Balance at the beginning of year $ 7,622 $ 6,393 Provision for bad debts 539 2,891 Charge-offs (3,924 ) (1,686 ) Recoveries - 24 Balance at the end of year $ 4,237 $ 7,622

Note 3 - Reserve for Sales Retu

Note 3 - Reserve for Sales Returns and Allowances	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Reserve For Sales Returns And Allowances Disclosure [Text Block]	NOTE 3 The activity in the reserve for sales returns and allowances was as follows (in thousands): Years Ended December 31, 2023 2022 Balance at the beginning of year $ 2,090 $ 2,636 Provision for returns and allowances 4,678 4,512 Actual returns and allowances paid to customers (5,360 ) (5,058 ) Balance at the end of year $ 1,408 $ 2,090

Note 4 - Inventories

Note 4 - Inventories	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 4 Inventories consisted of the following amounts (in thousands): December 31, 2023 2022 Finished goods $ 72,370 $ 94,228 Work in process 671 401 Raw materials 25,026 30,347 Inventories $ 98,067 $ 124,976

Note 5 - Property, Plant and Eq

Note 5 - Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 5 Property, plant and equipment, net, consisted of the following (in thousands): December 31, 2023 2022 Land $ 2,494 $ 2,494 Buildings, improvements and leaseholds 16,929 18,652 Machinery, equipment and fixtures 98,590 101,419 118,013 122,565 Accumulated depreciation (71,123 ) (71,173 ) Property, plant and equipment, net $ 46,890 $ 51,392 Depreciation expense was $9.4 million and $7.9 million in 2023 2022

Note 6 - Goodwill and Intangibl

Note 6 - Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Asset Impairment Charges [Text Block]	6 Goodwill Beginning in the second 2022, Note 17 350, During the third 2022, The fair value of goodwill in each impairment test was determined using a combination of an income approach, which estimates fair value based upon projections of future revenues, expenses, and cash flows discounted to their respective present values, and a market approach. The valuation methodology and underlying financial information included in the Company’s determination of fair value required significant judgments by management. The principal assumptions used in the Company’s discounted cash flow analysis consisted of (a) long-term projections of financial performance and (b) the weighted-average cost of capital of market participants, adjusted for the risk attributable to the Company and the industry in which it operates. Under the market approach, the principal assumption included an estimate of a control premium. Based on the goodwill impairment analysis performed, the Company determined that the estimated fair values of the previous Uniforms and Related Products segment and current Branded Products segment were lower than their carrying value primarily as the result of current market conditions, decline in expected cash flows and/or decrease in the Company’s stock price. Consequently, the Company recorded a non-cash goodwill impairment charge of $45.9 million during the year ended December 31, 2022. The following table presents the carrying amounts of goodwill attributable to each of the Company’s reportable segments (dollars in thousands): Branded Products Healthcare Apparel Total As of January 1, 2022: Gross goodwill $ 19,111 $ 20,323 $ 39,434 Accumulated impairment losses - - - Net goodwill $ 19,111 $ - $ 39,434 Additions $ 6,463 $ - $ 6,463 Impairment charge (25,595 ) (20,323 ) (45,918 ) Foreign currency translation 21 - 21 Net goodwill, December 31, 2022 $ - $ - $ - As of December 31, 2022: Gross goodwill $ 25,595 $ 20,323 $ 45,918 Accumulated impairment losses (25,595 ) (20,323 ) (45,918 ) Net goodwill $ - $ - $ - Intangible Assets In conjunction with the Company’s realignment of its reportable segments during the second 2022, no December 31, 2022. Indefinite-lived Intangible Assets Segment Carrying Amount, December 31, 2021 Impairment Charges Carrying Amount, December 31, 2022 Carrying Amount, December 31, 2023 Trade names: HPI Branded Products $ 4,700 $ - $ 4,700 $ 4,700 BAMKO Branded Products 8,900 - 8,900 8,900 Public Identity Branded Products 470 (470 ) - - Tangerine Branded Products 3,200 (3,200 ) - - Gifts By Design Branded Products 1,170 (1,170 ) - - Sutter’s Mill Branded Products 741 (741 ) - - CID Resources(1) Healthcare Apparel 14,160 - 14,160 14,160 Total $ 33,341 $ (5,581 ) $ 27,760 $ 27,760 ( 1 Includes trade names and trademarks associated with CID Resources, Wink™ and Zoey and Chloe. Intangible assets as of December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Item Weighted Average Life (In years) Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Definite-lived intangible assets: Customer relationships (7-15 year life) 11.7 $ 50,198 $ (27,417 ) $ 50,198 $ (23,330 ) Non-compete agreements (3-7 year life) 5.4 1,712 (1,507 ) 1,712 (1,367 ) Trademarks 10.0 414 (118 ) 379 (72 ) Trade names 2.0 710 (592 ) 710 (237 ) Total $ 53,034 $ (29,634 ) $ 52,999 $ (25,006 ) Indefinite-lived intangible assets: Trade names $ 27,760 $ 27,760 Total intangible assets $ 80,794 $ (29,634 ) $ 80,759 $ (25,006 ) Amortization expense for intangible assets for the years ended December 31, 2023 2022 Estimated future intangible amortization expense is as follows (in thousands): 2024 $ 3,719 2025 3,069 2026 3,061 2027 3,020 2028 2,671 Thereafter 7,860 Total $ 23,400

Note 7 - Other Current Liabilit

Note 7 - Other Current Liabilities	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 7 Other current liabilities consisted of the following (in thousands) December 31, 2023 2022 Salaries, wages, commissions and other compensation $ 14,599 $ 14,316 Contract liabilities 5,346 2,213 Accrued rebates 1,409 2,090 Current operating lease liabilities 4,231 3,135 Written put options 1,754 2,032 Other accrued expenses 16,639 14,860 Other current liabilities $ 43,978 $ 38,646

Note 8 - Long-term Debt

Note 8 - Long-term Debt	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Long-Term Debt [Text Block]	8 Debt consisted of the following (in thousands): December 31, 2023 2022 Credit Facilities: Revolving credit facility due August 2027 $ 25,000 $ 83,000 Term loan due August 2027 69,375 73,125 $ 94,375 $ 156,125 Less: Payments due within one year included in current liabilities 4,688 3,750 Debt issuance costs 898 808 Long-term debt less current maturities $ 88,789 $ 151,567 On August 23, 2022, August 2027 Obligations outstanding under the Credit Facilities accrue interest at a variable rate equal to the secured overnight financing rate (“SOFR”) plus an adjustment between 0.10% and 0.25% (depending on the applicable interest period) plus a margin between 1.0% and 2.0% (depending on the Company’s net leverage ratio). The weighted average interest rate on our outstanding borrowings under the Credit Facilities was 6.7% at December 31, 2023 December 31, 2023 Contractual principal payments for the term loan are as follows: 2024 2025 2026 2027 not The Credit Facilities are secured by substantially all of the operating assets of the Company, and the Company’s obligations under the Credit Facilities are guaranteed by all of its domestic subsidiaries. The Company’s obligations under the Credit Facilities are subject to acceleration upon the occurrence of an event of default as defined in the Credit Agreement. The Credit Agreement contains customary events of default and negative covenants, including but not 1.0 not 1.0. four December 31, 2023 Debt Maturity Schedule Contractual maturities of debt (excluding interest to be accrued thereon) at December 31, 2023 2024 $ 4,688 2025 5,625 2026 6,562 2027 77,500 2028 - Thereafter - Total debt $ 94,375

Note 9 - Income Tax Expense (Be

Note 9 - Income Tax Expense (Benefit)	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	9 The components of income (loss) before income tax expense are as follows (in thousands): Years Ended December 31, 2023 2022 Domestic $ (6,585 ) $ (59,407 ) Foreign 16,354 21,372 Income (loss) before income tax expense $ 9,769 $ (38,035 ) In 2022, 2023. Aggregate income tax provisions consists of the following (in thousands): Years Ended December 31, 2023 2022 Current: Federal $ 455 $ 3,580 State and local 401 1,314 Foreign 1,776 1,399 2,632 6,293 Deferred Taxes: Deferred tax benefit (1,635 ) (12,358 ) Income tax expense (benefit) $ 997 $ (6,065 ) The significant components of the deferred income tax asset (liability) are as follows (in thousands): December 31, 2023 2022 Deferred income tax assets: Pension accruals $ 3,578 $ 3,513 Operating reserves and other accruals 6,613 7,962 Book carrying value in excess of tax basis of intangibles 1,831 2,321 Capitalized research expenses 2,547 1,704 Disallowed interest 2,167 - Deferred income tax liabilities: Book carrying value in excess of tax basis of property (3,950 ) (4,183 ) Deferred expenses (430 ) (599 ) Net deferred income tax asset (liability) $ 12,356 $ 10,718 The difference between the total statutory Federal income tax rate and the actual effective income tax rate is accounted for as follows: Years Ended December 31, 2023 2022 Statutory federal income tax rate 21.0 % 21.0 % State and local income taxes, net of federal income tax benefit 2.5 % 3.4 % Rate impacts due to foreign operations (12.8 %) 4.3 % Compensation related 2.1 % (0.8 %) Pension termination - (0.3 %) R&D tax credits (2.7 %) 0.7 % Impairment charge - (11.7 %) Other 0.1 % (0.7 %) Effective income tax rate 10.2 % 15.9 % The effective tax rate is the result of a variety of factors, and is primarily dependent on our jurisdictional mix of earnings across the Company’s domestic and foreign operations as well as applicable statutory tax rates, the impact of goodwill and indefinite lived intangible impairments, and unrealized gains and losses associated with share-based compensation. The Tax Cuts and Jobs Act of 2017 The 2023 not not no The TCJA imposed a U.S. tax on GILTI that is earned by certain foreign affiliates owned by a U.S. shareholder. The computation of GILTI is generally intended to impose tax on the earnings of a foreign corporation that are deemed to exceed a certain threshold return relative to the underlying business investment. In accordance with guidance issued by FASB, the Company made a policy election to treat future taxes related to GILTI as a current period expense in the reporting period in which the tax is incurred. Deferred income taxes are provided on undistributed earnings of foreign subsidiaries in the period in which the Company determines it no not December 31, 2023 Only tax positions that meet the more-likely-than- not December 31, 2023 2022 not twelve $0.8 December 31, 2023 Changes in the Company’s gross liability for unrecognized tax benefits, excluding interest and penalties, are as follows (in thousands): December 31, 2023 2022 Balance at the beginning of year $ 807 $ 801 Additions for tax positions of prior years 105 129 Reductions due to lapse of statute of limitations (116 ) (123 ) Balance at the end of year $ 796 $ 807 We accrue interest and penalties related to unrecognized tax benefits in income tax expense, and the related liability is included in other long-term liabilities in our balance sheet. During the years ended December 31, 2023 2022 no December 31, 2023 2022 We anticipate that it is reasonably possible that the total amount of unrecognized tax benefits could decrease by approximately $0.1 twelve As a global organization, we file a U.S. federal income tax return as well as income tax returns in various states, and in non U.S. jurisdictions. As of December 31, 2023 2020 2022 2017 2022 2017 2022.

Note 10 - Benefit Plans

Note 10 - Benefit Plans	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Retirement Benefits [Text Block]	10 Defined Benefit Plans The Company is the sponsor of an unfunded supplemental executive retirement plan (“SERP”) which includes one December 31, 2023 may The following tables present the changes in the benefit obligations and the various plan assets, the funded status of the plans, and the amounts recognized in the Company’s balance sheets December 31, 2023 2022 December 31, 2023 2022 Changes in benefit obligation: Benefit obligation at beginning of year $ 12,993 $ 15,523 Service cost 21 203 Interest cost 637 401 Actuarial (gain) loss 229 (3,031 ) Benefits paid (280 ) (103 ) Benefit obligation at end of year 13,600 12,993 Changes in plan assets: Employer contributions 280 103 Benefits paid (280 ) (103 ) Fair value of plan assets at end of year - - Funded status at end of year $ (13,600 ) $ (12,993 ) Amounts recognized in balance sheets: Other current liabilities $ (316 ) $ (129 ) Long-term pension liability (13,284 ) (12,864 ) Net amount recognized $ (13,600 ) $ (12,993 ) Amounts recognized in accumulated other comprehensive loss consist of: Net actuarial loss $ 1,964 $ 1,953 Information for benefit plans with projected benefit obligation in excess of plan assets depicted as follows (in thousands): December 31, 2023 2022 Projected benefit obligation $ 13,600 $ 12,993 Fair value of plan assets - - Underfunded $ 13,600 $ 12,993 Components of net periodic benefit cost related to the SERP were as follows (in thousands): Years Ended December 31, 2023 2022 Service cost on benefits earned during the period $ 21 $ 203 Interest cost on projected benefit obligation 637 401 Recognized actuarial loss 218 1,715 Net periodic pension cost after settlements $ 876 $ 2,319 The service cost component is included in selling and administrative expenses in our statements of comprehensive income (loss) and the other components of net periodic pension cost are included in other periodic pension costs in our statements of comprehensive income (loss). The estimated net actuarial loss for the SERP that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is $0.1 million. The following table presents the weighted-average assumptions used to determine benefit obligations as of December 31, 2023 2022 Discount Rate Long Term Rate of Return Salary Scale 2022 4.93 % N/A 3.00 % 2023 4.73 % N/A 3.00 % The following table presents the weighted-average assumptions used to determine net periodic benefit cost for years ended December 31, 2023 2022 Discount Rate Long Term Rate of Return Salary Scale 2022 2.59 % N/A 3.00 % 2023 4.93 % N/A 3.00 % The following table includes projected benefit payments for the years indicated (in thousands): Year Projected Benefit Payments 2024 $ 324 2025 1,537 2026 977 2027 985 2028 975 2029-2033 4,733 Rabbi Trust December 31, 2023 2022 December 31, 2023 2022 In 2013, December 31, 2023 2022 December 31, 2023 2022 Defined Contribution Plan The Company provides a defined contribution plan covering qualified employees. The plan includes a provision that allows employees to make pre-tax contributions under Section 401 December 31, 2023 2022

Note 11 - Leases

Note 11 - Leases	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	11 The Company primarily leases factories, warehouses, call centers, office space and equipment for various terms under long-term, non-cancelable operating lease agreements. A right-of-use asset represents the Company’s right to use an underlying asset for the lease term and a lease liability represents the Company’s obligation to make lease payments arising from the lease. The Company’s leases generally have expected lease terms of one eight not December 31, 2023 December 31, 2022 not The components of lease cost were as follows (in thousands): Years Ended December 31, 2023 2022 Operating lease costs $ 4,495 $ 4,027 Short-term lease costs 609 889 Total lease costs $ 5,104 $ 4,916 Cash flow and noncash information related to our operating leases were as follows (in thousands): Years Ended December 31, 2023 2022 Operating cash flows – cash paid for operating lease liabilities $ 3,368 $ 2,996 Non-cash – Operating lease right-of-use assets obtained in exchange for new lease liabilities $ 13,908 $ 4,089 Other supplemental information related to our operating leases was as follows: Years Ended December 31, 2023 2022 Weighted-average remaining lease term (in years) 4.6 2.5 Weighted average discount rate 6.57 % 5.66 % Maturities of operating lease liabilities as of December 31, 2023 Operating Leases 2024 $ 4,315 2025 4,243 2026 3,994 2027 3,187 2028 2,811 Thereafter 1,680 Total lease payments 20,230 Less imputed interest 3,190 Present value of lease liabilities $ 17,040

Note 12 - Contingencies

Note 12 - Contingencies	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 12 The purchase price to acquire substantially all of the assets of Sutter’s Mill Specialties, Inc. (“Sutter’s Mill”) in December 2021 2022 2024. July 2023, first 2024. May 2022 April 2025. December 31, 2023 third 2024. December 31, 2023 2022 may may The Company is involved in various legal actions and claims arising from the normal course of business. In the opinion of management, the ultimate outcome of these matters is not

Note 13 - Share-based Compensat

Note 13 - Share-based Compensation	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	13 In May 2013, 2013 “2013 May 2022, 2022 “2022 2022 December 31, 2023 2022 2022 2013 No 2013 2013 Share-based compensation is recorded in selling and administrative expense in the statements of comprehensive income (loss). The following table details the share-based compensation expense by type of award and the total related tax benefit for the periods presented (in thousands): Years Ended December 31, 2023 2022 Stock options and SARs $ 1,279 $ 1,472 Restricted stock 2,560 2,598 Performance shares (52 ) 219 Total share-based compensation expense $ 3,787 $ 4,289 Related income tax benefit $ 767 $ 804 Stock Options and Stock Appreciation Rights (“SARs”) The Company grants stock options and stock-settled SARs to employees that allow them to purchase shares of the Company’s common stock. Stock options are also granted to outside members of the Board of Directors of the Company. The Company determines the fair value of stock options and SARs at the date of grant using the Black-Scholes valuation model. Assumptions regarding volatility, risk-free interest rate, expected term and dividend yield are required for the Black-Scholes model. The risk-free interest rate is based on the yield of a U.S. treasury bond with a similar maturity to the award’s expected life. The expected life for awards granted is based on the historical exercise patterns experienced by the Company when the award is made. The determination of expected stock price volatility for awards is based on historical Superior common stock prices over a period commensurate with the expected life. The dividend yield assumption is based on the history and expectation of the Company’s dividend payouts. The following table summarizes significant assumptions utilized to determine the fair value of stock options and SARs: Years Ended December 31, 2023 2022 Stock Options: Risk free interest rate 3.5% 4.9% 1.6% 3.8% Expected award life (years) 3-10 3-10 Expected volatility 46.9% 67.8% 46.8% 65.0% Expected dividend yield 4.7% 7.1% 2.4% 5.6% Weighted average fair value per share at grant date $ 4.14 $ 5.39 SARs: Risk free interest rate 4.0 % 1.6% - 3.8% Expected award life (years) 3 3-4 Expected volatility 67.8 % 61.6% - 64.8% Expected dividend yield 4.7 % 2.4% - 5.6% Weighted average fair value per share at grant date $ 4.58 $ 6.34 All stock options and SARs granted prior to August 3, 2018 one three five ten 2013 2022 A summary of stock option transactions during the year ended December 31, 2023 Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 962,775 $ 15.89 3.26 $ 301 Granted 200,091 11.37 Exercised (28,728 ) 9.55 Lapsed or cancelled (180,962) 17.99 Outstanding, December 31, 2023 953,176 14.73 2.80 1,718 Exercisable, December 31, 2023 501,610 16.18 1.63 813 Intrinsic value is the difference between the market value of our common stock and the exercise price of each stock option multiplied by the number of stock options outstanding for those stock options where the market value exceeds their exercise price. Options exercised during the years ended December 31, 2023 2022 December 31, 2023 2022 No December 31, 2023 2022 December 31, 2023 2022 December 31, 2023 A summary of stock-settled SARs transactions during the year ended December 31, 2023 Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 320,385 $ 15.23 2.23 $ 69 Granted 51,209 12.04 Exercised (41,226 ) 9.83 Lapsed or cancelled (37,860 ) 23.62 Outstanding, December 31, 2023 292,508 14.35 2.07 506 Exercisable, December 31, 2023 184,245 14.29 1.10 361 SARs exercised during the years ended December 31, 2023 2022 No December 31, 2023 2022 December 31, 2023 one Restricted Stock three five 2013 2022 A summary of restricted stock transactions during the year ended December 31, 2023 Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 372,470 $ 20.45 Granted 155,213 11.53 Vested (99,317 ) 16.46 Forfeited - - Outstanding, December 31, 2023 428,366 18.14 As of December 31, 2023 Performance Shares The Company has granted performance shares, which either contain only service-based vesting conditions or service-based and performance-based vesting conditions. The service-based awards vest after the service period is met, which is generally three five five 2013 2022 A summary of performance share transactions during the year ended December 31, 2023 Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 199,451 $ 20.57 Granted 94,028 12.56 Vested (4,558 ) 20.54 Forfeited (5,400 ) 9.48 Outstanding, December 31, 2023 283,521 18.13 As of December 31, 2023

Note 14 - Net Income (Loss) Per

Note 14 - Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	14 The Company’s basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding for the period. Diluted net income (loss) per share includes the effect of the Company’s outstanding stock options, stock appreciation rights, unvested shares of restricted stock and unvested performance shares, if the inclusion of these items is dilutive. The following table presents a reconciliation of basic and diluted net income (loss) per share for the years ended December 31, 2023 2022 Years Ended December 31, 2023 2022 Net income (loss) used in the computation of basic and diluted net income per share (in thousands) $ 8,772 $ (31,970 ) Weighted average shares outstanding - basic 15,968,199 15,764,859 Dilutive common stock equivalents 191,109 - Weighted average shares outstanding - diluted 16,159,308 15,764,859 Net income (loss) per share: Basic $ 0.55 $ (2.03 ) Diluted $ 0.54 $ (2.03 ) Diluted weighted average shares outstanding excludes shares of common stock of 400,381 for the year ended December 31, 2022 Awards to purchase 1,113,935 and 687,117 shares of common stock with weighted average exercise prices of $15.95 and $21.06, were outstanding during the years ended December 31, 2023 2022 not

Note 15 - Net Sales

Note 15 - Net Sales	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	15 For our Branded Products and Healthcare Apparel segments, revenue is primarily generated from the sale of finished products to customers. Revenues for our Branded Products and Healthcare Apparel segments are recognized when the performance obligations under the contract terms are satisfied. For certain contracts with customers in which the Company has an enforceable right to payment for goods with no not For our Contact Centers segment, revenue is generated from providing our customers with contact center services. Revenue for our Contact Centers segment is recognized as services are delivered. Revenue is measured at the amount of consideration we expect to receive in exchange for the goods or services. Variable consideration for estimated returns, allowances and other price variances is recorded based upon historical experience and current allowance programs. Contract terms may not not one one The following table presents disaggregated revenue by operating segment for the periods presented (in thousands): Years Ended December 31, 2023 2022 Branded Products Segment: Branded products $ 342,456 $ 381,363 Personal protective equipment 224 6,568 Total Branded Products Segment $ 342,680 $ 387,931 Healthcare Apparel Segment: Healthcare apparel $ 110,871 $ 110,505 Personal protective equipment 3,007 2,816 Total Healthcare Apparel Segment $ 113,878 $ 113,321 Contact Centers Segment: Contact centers services $ 91,500 $ 84,218 Net intersegment eliminations (4,756 ) (6,639 ) Total Contact Centers Segment $ 86,744 $ 77,579 Consolidated Net Sales $ 543,302 $ 578,831 Contract Assets and Contract Liabilities The following table provides information about accounts receivable, contract assets and contract liabilities from contracts with customers (in thousands): December 31, 2023 2022 Accounts receivable $ 103,494 $ 104,813 Current contract assets 48,715 52,980 Current contract liabilities 5,346 2,213 Contract assets relate to goods produced without an alternative use for which the Company has an enforceable right to payment but which has not December 31, 2022 December 31, 2023 December 31, 2023 December 31, 2022

Note 16 - Stock Repurchase Plan

Note 16 - Stock Repurchase Plan	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Equity [Text Block]	NOTE 16 – Stock Repurchase Plan: On May 2, 2019, no not December 31, 2023 2022 December 31, 2023

Note 17 - Operating Segment Inf

Note 17 - Operating Segment Information	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	17 The Company manages and reports the following segments: Branded Products segment: Healthcare Apparel segment: third Contact Centers: Intersegment eliminations include the elimination of revenues and costs from services provided by the Contact Centers segment to the Company’s two not No 10% 2023 2022 During the fourth 2023, not The following tables set forth financial information related to the Company’s operating segments (in thousands): Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Year Ended December 31, 2023: Net sales $ 342,680 $ 113,878 $ 91,500 $ (4,756 ) $ - $ 543,302 Segment Adjusted EBITDA 33,146 7,997 12,408 - (20,069 ) $ 33,482 Supplemental information: Depreciation and amortization $ 6,744 $ 3,925 $ 2,942 $ - $ 384 $ 13,995 Capital expenditures $ 2,550 $ 960 $ 1,392 $ - $ 61 $ 4,963 Total assets $ 218,018 $ 131,168 $ 40,941 $ - $ 32,323 $ 422,450 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Year Ended December 31, 2022: Net sales $ 387,931 $ 113,321 $ 84,218 $ (6,639 ) $ - $ 578,831 Segment Adjusted EBITDA 31,144 (2,747 ) 18,521 - (18,991 ) 27,927 Supplemental information: Depreciation and amortization $ 6,465 $ 3,946 $ 2,373 $ - $ 220 $ 13,004 Capital expenditures $ 4,643 $ 1,169 $ 4,876 $ - $ 330 $ 11,018 Total assets $ 224,116 $ 150,335 $ 43,368 $ - $ 39,122 $ 456,941 The following table reconciles total Segment Adjusted EBITDA to income (loss) before income tax expense: Years Ended December 31, 2023 2022 Income (loss) before income tax expense $ 9,769 $ (38,035 ) Interest expense 9,718 4,894 Depreciation and amortization 13,995 13,004 Goodwill impairment charge - 45,918 Intangible assets impairment charge - 5,581 Gain on sale of property, plant and equipment - (3,435 ) Segment Adjusted EBITDA $ 33,482 $ 27,927

Note 18 - Acquisition of Busine

Note 18 - Acquisition of Businesses	12 Months Ended
	Dec. 31, 2023
Notes to Financial Statements
Business Combination Disclosure [Text Block]	18 : Guardian Products, Inc. On May 1, 2022, one three April 2025. three Fair Value of Consideration Transferred A summary of the purchase price is as follows (in thousands): Cash consideration $ 11,077 Restricted shares of Superior common stock issued 2,000 Contingent consideration 1,119 Total Consideration $ 14,196 Assets Acquired and Liabilities Assumed The following table presents the allocation of the total fair value of consideration transferred, as shown above, to the acquired tangible and intangible assets and liabilities of Guardian based on their estimated fair values as of the effective date of the transaction (in thousands): Accounts receivable $ 1,656 Inventories 621 Prepaid expenses and other current assets 272 Property, plant and equipment 15 Intangible assets 5,886 Goodwill 6,463 Total assets $ 14,913 Accounts payable 533 Other current liabilities 184 Total liabilities $ 717 The Company recorded $5.9 million in identifiable intangibles at fair value, consisting of $5.0 million in acquired customer relationships, $0.2 million for a non-compete agreement and $0.7 million for the Guardian Products trade name. The intangible assets associated with the customer relationships are being amortized for seven five two The difference between the fair value of the consideration transferred and the values assigned to the assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities. The acquisition of Guardian was treated as an asset purchase for income tax purpose, and therefore, the resulting goodwill from this acquisition is deductible for U.S. income tax purposes. The goodwill associated with the Guardian acquisition was fully impaired during the year ended December 31, 2022 third 2022, Note 6

Insider Trading Arrangements

Insider Trading Arrangements	12 Months Ended
	Dec. 31, 2023
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	9B. Other Information During the quarter ended December 31, 2023 no 408
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation The accompanying consolidated financial statements of Superior included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) (“U.S.” or “United States”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company refers to the consolidated financial statements collectively as “financial statements,” and individually as “statements of comprehensive income (loss),” “balance sheets,” “statements of shareholders’ equity,” and “statements of cash flows” herein.
Segment Reporting, Policy [Policy Text Block]	Reportable Segments Beginning in the second 2022, not no Note 6
Use of Estimates, Policy [Policy Text Block]	Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses, as well as the disclosures of contingent assets and liabilities. Because of the inherent uncertainties in this process, actual future results could differ from those expected at the reporting date.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents The Company considers all highly liquid investments with an original maturity of three
Revenue [Policy Text Block]	Revenue recognition Revenue is recognized when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. See Note 15
Accounts Receivable [Policy Text Block]	Accounts receivable and allowance for doubtful accounts Judgments and estimates are used in determining the collectability of accounts receivable and in establishing allowances for doubtful accounts. The Company analyzes specific accounts receivable and historical bad debt experience, customer credit worthiness, current economic trends and the age of outstanding balances when evaluating the adequacy of the allowance for doubtful accounts. Changes in estimates are reflected in the period they become known. Charge-offs of accounts receivable are made once all collection efforts have been exhausted. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may
Cost Of Goods Sold And Shipping And Handling Fees And Costs, Policy [Policy Text Block]	Cost of goods sold and shipping and handling fees and costs Cost of goods sold for our Branded Products segment and our Healthcare Apparel segment consist primarily of direct costs of acquiring inventory, including cost of merchandise, inbound freight charges, purchasing, receiving and inspection costs. Cost of goods sold for our Contact Centers segment includes salaries and payroll related benefits for agents. The Company includes shipping and handling fees billed to customers in net sales. Shipping and handling costs associated with out-bound freight are recorded in cost of goods sold. The cost of occupancy and operating the Company’s distribution centers are included in selling and administrative expenses.
Inventory, Policy [Policy Text Block]	Inventories Inventories are stated at the lower of cost ( first first may
Property, Plant and Equipment, Policy [Policy Text Block]	Property, plant and equipment Property, plant and equipment are stated at cost, less accumulated depreciation. Major renewals and improvements are capitalized, while replacements, maintenance and repairs which do not 31, 2022, Property, plant and equipment is recorded at cost and depreciated using the straight-line method over its estimated useful life as follows: Buildings (in years) 20 to 40 Improvements (in years) 5 to 40 Machinery, equipment and fixtures (in years) 3 to 10 Leasehold improvements are depreciated over the terms of the leases to the extent that such improvements have useful lives of at least the terms of the respective leases.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long-lived assets Long-lived assets, such as property and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not no December 31, 2023 2022
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and indefinite-lived intangible assets The Company has made acquisitions in the past that included goodwill and indefinite-lived intangible assets. Goodwill represents the excess of the cost of an acquisition over the fair value of the net assets acquired. Goodwill and indefinite-lived intangible assets such as trade names are not fourth may not • macroeconomic conditions such as deterioration in general economic conditions, limitations on accessing capital, or other developments in equity and credit markets; • industry and market considerations such as a deterioration in the environment in which the Company operates, an increased competitive environment, a decline in market-dependent multiples or metrics (considered in both absolute terms and relative to peers), a change in the market for the Company’s products or services, or a regulatory or political development; • cost factors such as increases in raw materials, labor, or other costs that have a negative effect on earnings and cash flows; • overall financial performance such as negative or declining cash flows or a decline in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods; and • other relevant entity-specific events such as changes in management, key personnel, strategy, or customers. An entity has the option to first not 50% not not three In conjunction with the re-segmentation during the second 2022, third 2022, December 31, 2022. December 31, 2022, no In conjunction with the Company’s realignment of its reportable segments during the second 2022, no December 31, 2022. For the year ended December 31, 2023, December 31, 2023 2022
Business Combinations Policy [Policy Text Block]	Contingent Consideration Contingent consideration relating to consideration transferred in exchange for an acquired business is recognized at its estimated fair value at the acquisition date. The contingent consideration is remeasured to fair value at each reporting date until the contingency is resolved. Recognition of any changes in fair value are included in selling and administrative expenses in our statements of comprehensive income (loss).
Pension and Other Postretirement Plans, Policy [Policy Text Block]	SERP The Company is the sponsor of an unfunded supplemental executive retirement plan (“SERP”) which includes one
Insurance [Policy Text Block]	Insurance The Company self-insures for certain obligations related to employee health programs. The Company also purchases stop-loss insurance policies to protect it from catastrophic losses. Judgments and estimates are used in determining the potential value associated with reported claims and for losses that have occurred, but have not may
Income Tax, Policy [Policy Text Block]	Taxes on income Income taxes are provided for under the asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not not Note 9
Share-Based Payment Arrangement [Policy Text Block]	Share-based compensation The Company awards share-based compensation as an incentive for employees to contribute to the Company’s long-term success. The Company grants options, stock-settled stock appreciation rights, restricted stock and performance shares. The Company recognizes share-based compensation expense for all awards granted to employees, which is based on the fair value of the award on the date of grant. Determining the appropriate fair value model and calculating the fair value of stock compensation awards requires the input of certain highly complex and subjective assumptions, including the expected life of the stock compensation awards and the Company’s common stock price volatility, risk free interest rate and dividend rate. The assumptions used in calculating the fair value of stock compensation awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of judgment. As a result, if factors change and the Company deems it necessary to use different assumptions, stock compensation expense could be materially different from what has been recorded in the current period.
Comprehensive Income, Policy [Policy Text Block]	Other comprehensive income (loss) Comprehensive income (loss) includes net income (loss) and all other changes in equity during a period except those resulting from investments by or distributions to shareholders. Other comprehensive income (loss) consists of defined benefit pension plans activities, cash flow hedging activities and foreign currency translation adjustment. The related tax effects of these items are recorded in income tax expense (benefit) within the statements of comprehensive income (loss), upon reclassification from accumulated other comprehensive income (loss), net of tax.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translations and Transactions Assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the current rate of exchange on the last day of the reporting period. Changes in the carrying values of these assets and liabilities attributable to fluctuations in spot rates are recognized in net foreign currency translation adjustment, a component of accumulated other comprehensive income (loss), net of tax. Monetary assets and liabilities denominated in a currency that is different from a reporting entity’s functional currency are remeasured from the applicable currency to the reporting entity’s functional currency. Gains or losses resulting from transactions denominated in other currencies are recognized in net income (loss) each period. The majority of the Company’s transactions are settled in U.S. dollars.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Risks and concentrations Financial instruments that potentially subject the Company to concentrations of credit risk include cash in banks in excess of federally insured amounts. The Company manages this risk by maintaining all deposits in high quality financial institutions and periodically performing evaluations of the relative credit standing of the financial institutions. When assessing credit risk the Company considers whether the credit risk exists at both the individual and group level. Consideration is given to the activity, region and economic characteristics when assessing if there exists a group concentration risk. At December 31, 2023 2022 no 10 December 31, 2023 2022 five none 10% 2023 no 10% 2023 Principal raw materials used to manufacture the Company’s finished goods include cotton, polyester, spandex, cotton-synthetic, poly-synthetic blends, textiles, plastic, glass, fabric and metal. The majority of such fabrics are sourced in China, either directly by us or our suppliers. If we are unable to continue to obtain our raw materials and finished products from China or if our suppliers are unable to source raw materials from China, it could significantly disrupt our business. Further, the Company and the Company’s suppliers generally source or manufacture finished goods in parts of the world that may
Derivatives, Reporting of Derivative Activity [Policy Text Block]	Written Put Options During the second 2022, twenty-four December 31, 2023 480, December 31, 2023 2022 31, 2023 2022 December 31, 2023
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair value of financial instruments The carrying amounts of cash and cash equivalents, receivables and accounts payable approximated fair value as of December 31, 2023 2022
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not not Recently Issued Accounting Pronouncements Not In November 2023, 2023 07, "Segment Reporting (Topic 280 December 15, 2023, December 15, 2024. not In December 2023, 2023 09, "Income Taxes (Topic 740 December 15, 2024. not not

Note 1 - Description of Busin_2

Note 1 - Description of Business, Basis of Presentation and Summary of Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Property, Plant and Equipment, Useful Life [Table Text Block]	Buildings (in years) 20 to 40 Improvements (in years) 5 to 40 Machinery, equipment and fixtures (in years) 3 to 10

Note 2 - Allowance for Doubtf_2

Note 2 - Allowance for Doubtful Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Financing Receivable, Allowance for Credit Loss [Table Text Block]	Years Ended December 31, 2023 2022 Balance at the beginning of year $ 7,622 $ 6,393 Provision for bad debts 539 2,891 Charge-offs (3,924 ) (1,686 ) Recoveries - 24 Balance at the end of year $ 4,237 $ 7,622

Note 3 - Reserve for Sales Re_2

Note 3 - Reserve for Sales Returns and Allowances (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Reserve for Sales Returns and Allowances [Table Text Block]	Years Ended December 31, 2023 2022 Balance at the beginning of year $ 2,090 $ 2,636 Provision for returns and allowances 4,678 4,512 Actual returns and allowances paid to customers (5,360 ) (5,058 ) Balance at the end of year $ 1,408 $ 2,090

Note 4 - Inventories (Tables)

Note 4 - Inventories (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2023 2022 Finished goods $ 72,370 $ 94,228 Work in process 671 401 Raw materials 25,026 30,347 Inventories $ 98,067 $ 124,976

Note 5 - Property, Plant and _2

Note 5 - Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2023 2022 Land $ 2,494 $ 2,494 Buildings, improvements and leaseholds 16,929 18,652 Machinery, equipment and fixtures 98,590 101,419 118,013 122,565 Accumulated depreciation (71,123 ) (71,173 ) Property, plant and equipment, net $ 46,890 $ 51,392

Note 6 - Goodwill and Intangi_2

Note 6 - Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Goodwill [Table Text Block]	Branded Products Healthcare Apparel Total As of January 1, 2022: Gross goodwill $ 19,111 $ 20,323 $ 39,434 Accumulated impairment losses - - - Net goodwill $ 19,111 $ - $ 39,434 Additions $ 6,463 $ - $ 6,463 Impairment charge (25,595 ) (20,323 ) (45,918 ) Foreign currency translation 21 - 21 Net goodwill, December 31, 2022 $ - $ - $ - As of December 31, 2022: Gross goodwill $ 25,595 $ 20,323 $ 45,918 Accumulated impairment losses (25,595 ) (20,323 ) (45,918 ) Net goodwill $ - $ - $ -
Schedule of Indefinite-Lived Intangible Assets [Table Text Block]	Indefinite-lived Intangible Assets Segment Carrying Amount, December 31, 2021 Impairment Charges Carrying Amount, December 31, 2022 Carrying Amount, December 31, 2023 Trade names: HPI Branded Products $ 4,700 $ - $ 4,700 $ 4,700 BAMKO Branded Products 8,900 - 8,900 8,900 Public Identity Branded Products 470 (470 ) - - Tangerine Branded Products 3,200 (3,200 ) - - Gifts By Design Branded Products 1,170 (1,170 ) - - Sutter’s Mill Branded Products 741 (741 ) - - CID Resources(1) Healthcare Apparel 14,160 - 14,160 14,160 Total $ 33,341 $ (5,581 ) $ 27,760 $ 27,760
Schedule of Finite-lived and Indefinite-Lived Intangible Assets [Table Text Block]	December 31, 2023 December 31, 2022 Item Weighted Average Life (In years) Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Definite-lived intangible assets: Customer relationships (7-15 year life) 11.7 $ 50,198 $ (27,417 ) $ 50,198 $ (23,330 ) Non-compete agreements (3-7 year life) 5.4 1,712 (1,507 ) 1,712 (1,367 ) Trademarks 10.0 414 (118 ) 379 (72 ) Trade names 2.0 710 (592 ) 710 (237 ) Total $ 53,034 $ (29,634 ) $ 52,999 $ (25,006 ) Indefinite-lived intangible assets: Trade names $ 27,760 $ 27,760 Total intangible assets $ 80,794 $ (29,634 ) $ 80,759 $ (25,006 )
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2024 $ 3,719 2025 3,069 2026 3,061 2027 3,020 2028 2,671 Thereafter 7,860 Total $ 23,400

Note 7 - Other Current Liabil_2

Note 7 - Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	December 31, 2023 2022 Salaries, wages, commissions and other compensation $ 14,599 $ 14,316 Contract liabilities 5,346 2,213 Accrued rebates 1,409 2,090 Current operating lease liabilities 4,231 3,135 Written put options 1,754 2,032 Other accrued expenses 16,639 14,860 Other current liabilities $ 43,978 $ 38,646

Note 8 - Long-term Debt (Tables

Note 8 - Long-term Debt (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Long-Term Debt Instruments [Table Text Block]	December 31, 2023 2022 Credit Facilities: Revolving credit facility due August 2027 $ 25,000 $ 83,000 Term loan due August 2027 69,375 73,125 $ 94,375 $ 156,125 Less: Payments due within one year included in current liabilities 4,688 3,750 Debt issuance costs 898 808 Long-term debt less current maturities $ 88,789 $ 151,567
Schedule of Maturities of Long-Term Debt [Table Text Block]	2024 $ 4,688 2025 5,625 2026 6,562 2027 77,500 2028 - Thereafter - Total debt $ 94,375

Note 9 - Income Tax Expense (_2

Note 9 - Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	Years Ended December 31, 2023 2022 Domestic $ (6,585 ) $ (59,407 ) Foreign 16,354 21,372 Income (loss) before income tax expense $ 9,769 $ (38,035 )
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Years Ended December 31, 2023 2022 Current: Federal $ 455 $ 3,580 State and local 401 1,314 Foreign 1,776 1,399 2,632 6,293 Deferred Taxes: Deferred tax benefit (1,635 ) (12,358 ) Income tax expense (benefit) $ 997 $ (6,065 )
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2023 2022 Deferred income tax assets: Pension accruals $ 3,578 $ 3,513 Operating reserves and other accruals 6,613 7,962 Book carrying value in excess of tax basis of intangibles 1,831 2,321 Capitalized research expenses 2,547 1,704 Disallowed interest 2,167 - Deferred income tax liabilities: Book carrying value in excess of tax basis of property (3,950 ) (4,183 ) Deferred expenses (430 ) (599 ) Net deferred income tax asset (liability) $ 12,356 $ 10,718
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Years Ended December 31, 2023 2022 Statutory federal income tax rate 21.0 % 21.0 % State and local income taxes, net of federal income tax benefit 2.5 % 3.4 % Rate impacts due to foreign operations (12.8 %) 4.3 % Compensation related 2.1 % (0.8 %) Pension termination - (0.3 %) R&D tax credits (2.7 %) 0.7 % Impairment charge - (11.7 %) Other 0.1 % (0.7 %) Effective income tax rate 10.2 % 15.9 %
Summary of Income Tax Contingencies [Table Text Block]	December 31, 2023 2022 Balance at the beginning of year $ 807 $ 801 Additions for tax positions of prior years 105 129 Reductions due to lapse of statute of limitations (116 ) (123 ) Balance at the end of year $ 796 $ 807

Note 10 - Benefit Plans (Tables

Note 10 - Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Defined Benefit Plans Disclosures [Table Text Block]	December 31, 2023 2022 Changes in benefit obligation: Benefit obligation at beginning of year $ 12,993 $ 15,523 Service cost 21 203 Interest cost 637 401 Actuarial (gain) loss 229 (3,031 ) Benefits paid (280 ) (103 ) Benefit obligation at end of year 13,600 12,993 Changes in plan assets: Employer contributions 280 103 Benefits paid (280 ) (103 ) Fair value of plan assets at end of year - - Funded status at end of year $ (13,600 ) $ (12,993 ) Amounts recognized in balance sheets: Other current liabilities $ (316 ) $ (129 ) Long-term pension liability (13,284 ) (12,864 ) Net amount recognized $ (13,600 ) $ (12,993 ) Amounts recognized in accumulated other comprehensive loss consist of: Net actuarial loss $ 1,964 $ 1,953
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]	December 31, 2023 2022 Projected benefit obligation $ 13,600 $ 12,993 Fair value of plan assets - - Underfunded $ 13,600 $ 12,993
Schedule of Net Benefit Costs [Table Text Block]	Years Ended December 31, 2023 2022 Service cost on benefits earned during the period $ 21 $ 203 Interest cost on projected benefit obligation 637 401 Recognized actuarial loss 218 1,715 Net periodic pension cost after settlements $ 876 $ 2,319
Defined Benefit Plan, Assumptions [Table Text Block]	Discount Rate Long Term Rate of Return Salary Scale 2022 4.93 % N/A 3.00 % 2023 4.73 % N/A 3.00 % Discount Rate Long Term Rate of Return Salary Scale 2022 2.59 % N/A 3.00 % 2023 4.93 % N/A 3.00 %
Schedule of Expected Benefit Payments [Table Text Block]	Year Projected Benefit Payments 2024 $ 324 2025 1,537 2026 977 2027 985 2028 975 2029-2033 4,733

Note 11 - Leases (Tables)

Note 11 - Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Lease, Cost [Table Text Block]	Years Ended December 31, 2023 2022 Operating lease costs $ 4,495 $ 4,027 Short-term lease costs 609 889 Total lease costs $ 5,104 $ 4,916 Years Ended December 31, 2023 2022 Operating cash flows – cash paid for operating lease liabilities $ 3,368 $ 2,996 Non-cash – Operating lease right-of-use assets obtained in exchange for new lease liabilities $ 13,908 $ 4,089 Years Ended December 31, 2023 2022 Weighted-average remaining lease term (in years) 4.6 2.5 Weighted average discount rate 6.57 % 5.66 %
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Operating Leases 2024 $ 4,315 2025 4,243 2026 3,994 2027 3,187 2028 2,811 Thereafter 1,680 Total lease payments 20,230 Less imputed interest 3,190 Present value of lease liabilities $ 17,040

Note 13 - Share-based Compens_2

Note 13 - Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Years Ended December 31, 2023 2022 Stock options and SARs $ 1,279 $ 1,472 Restricted stock 2,560 2,598 Performance shares (52 ) 219 Total share-based compensation expense $ 3,787 $ 4,289 Related income tax benefit $ 767 $ 804
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Years Ended December 31, 2023 2022 Stock Options: Risk free interest rate 3.5% 4.9% 1.6% 3.8% Expected award life (years) 3-10 3-10 Expected volatility 46.9% 67.8% 46.8% 65.0% Expected dividend yield 4.7% 7.1% 2.4% 5.6% Weighted average fair value per share at grant date $ 4.14 $ 5.39 SARs: Risk free interest rate 4.0 % 1.6% - 3.8% Expected award life (years) 3 3-4 Expected volatility 67.8 % 61.6% - 64.8% Expected dividend yield 4.7 % 2.4% - 5.6% Weighted average fair value per share at grant date $ 4.58 $ 6.34
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 962,775 $ 15.89 3.26 $ 301 Granted 200,091 11.37 Exercised (28,728 ) 9.55 Lapsed or cancelled (180,962) 17.99 Outstanding, December 31, 2023 953,176 14.73 2.80 1,718 Exercisable, December 31, 2023 501,610 16.18 1.63 813
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]	Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 320,385 $ 15.23 2.23 $ 69 Granted 51,209 12.04 Exercised (41,226 ) 9.83 Lapsed or cancelled (37,860 ) 23.62 Outstanding, December 31, 2023 292,508 14.35 2.07 506 Exercisable, December 31, 2023 184,245 14.29 1.10 361
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 372,470 $ 20.45 Granted 155,213 11.53 Vested (99,317 ) 16.46 Forfeited - - Outstanding, December 31, 2023 428,366 18.14
Schedule of Nonvested Performance-Based Units Activity [Table Text Block]	Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 199,451 $ 20.57 Granted 94,028 12.56 Vested (4,558 ) 20.54 Forfeited (5,400 ) 9.48 Outstanding, December 31, 2023 283,521 18.13

Note 14 - Net Income (Loss) P_2

Note 14 - Net Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Years Ended December 31, 2023 2022 Net income (loss) used in the computation of basic and diluted net income per share (in thousands) $ 8,772 $ (31,970 ) Weighted average shares outstanding - basic 15,968,199 15,764,859 Dilutive common stock equivalents 191,109 - Weighted average shares outstanding - diluted 16,159,308 15,764,859 Net income (loss) per share: Basic $ 0.55 $ (2.03 ) Diluted $ 0.54 $ (2.03 )

Note 15 - Net Sales (Tables)

Note 15 - Net Sales (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Disaggregation of Revenue [Table Text Block]	Years Ended December 31, 2023 2022 Branded Products Segment: Branded products $ 342,456 $ 381,363 Personal protective equipment 224 6,568 Total Branded Products Segment $ 342,680 $ 387,931 Healthcare Apparel Segment: Healthcare apparel $ 110,871 $ 110,505 Personal protective equipment 3,007 2,816 Total Healthcare Apparel Segment $ 113,878 $ 113,321 Contact Centers Segment: Contact centers services $ 91,500 $ 84,218 Net intersegment eliminations (4,756 ) (6,639 ) Total Contact Centers Segment $ 86,744 $ 77,579 Consolidated Net Sales $ 543,302 $ 578,831
Schedule of Accounts Receivables and Contract Assets [Table Text Block]	December 31, 2023 2022 Accounts receivable $ 103,494 $ 104,813 Current contract assets 48,715 52,980 Current contract liabilities 5,346 2,213

Note 17 - Operating Segment I_2

Note 17 - Operating Segment Information (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Year Ended December 31, 2023: Net sales $ 342,680 $ 113,878 $ 91,500 $ (4,756 ) $ - $ 543,302 Segment Adjusted EBITDA 33,146 7,997 12,408 - (20,069 ) $ 33,482 Supplemental information: Depreciation and amortization $ 6,744 $ 3,925 $ 2,942 $ - $ 384 $ 13,995 Capital expenditures $ 2,550 $ 960 $ 1,392 $ - $ 61 $ 4,963 Total assets $ 218,018 $ 131,168 $ 40,941 $ - $ 32,323 $ 422,450 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Year Ended December 31, 2022: Net sales $ 387,931 $ 113,321 $ 84,218 $ (6,639 ) $ - $ 578,831 Segment Adjusted EBITDA 31,144 (2,747 ) 18,521 - (18,991 ) 27,927 Supplemental information: Depreciation and amortization $ 6,465 $ 3,946 $ 2,373 $ - $ 220 $ 13,004 Capital expenditures $ 4,643 $ 1,169 $ 4,876 $ - $ 330 $ 11,018 Total assets $ 224,116 $ 150,335 $ 43,368 $ - $ 39,122 $ 456,941
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Years Ended December 31, 2023 2022 Income (loss) before income tax expense $ 9,769 $ (38,035 ) Interest expense 9,718 4,894 Depreciation and amortization 13,995 13,004 Goodwill impairment charge - 45,918 Intangible assets impairment charge - 5,581 Gain on sale of property, plant and equipment - (3,435 ) Segment Adjusted EBITDA $ 33,482 $ 27,927

Note 18 - Acquisition of Busi_2

Note 18 - Acquisition of Businesses (Tables)	12 Months Ended
	Dec. 31, 2023
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Cash consideration $ 11,077 Restricted shares of Superior common stock issued 2,000 Contingent consideration 1,119 Total Consideration $ 14,196
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Accounts receivable $ 1,656 Inventories 621 Prepaid expenses and other current assets 272 Property, plant and equipment 15 Intangible assets 5,886 Goodwill 6,463 Total assets $ 14,913 Accounts payable 533 Other current liabilities 184 Total liabilities $ 717

Note 1 - Description of Busin_3

Note 1 - Description of Business, Basis of Presentation and Summary of Accounting Policies (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Proceeds from Sale of Property, Plant, and Equipment	$ 0	$ 4,795
Gain (Loss) on Disposition of Assets		3,400
Goodwill, Impairment Loss	0	45,918
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)	0	5,581
Unrealized Gain (Loss) on Derivatives	$ (489)	1,565
Options Held [Member]
Derivative, Underlying Investment, Shares (in shares)	132,924		207,970
Derivative, Underlying Investment, Fair Value	$ 1,800	2,000	$ 3,600
Open Option Contracts, Expiration Period (Month)			24 months
Derivative, Underlying Investment, Shares, Expirations in Period (in shares)	75,046
Increase (Decrease) in Derivative Liabilities	$ 800
Unrealized Gain (Loss) on Derivatives	(500)	1,600
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Five Largest [Member]
Accounts Receivable, after Allowance for Credit Loss	$ 17,900	$ 21,400
Concentration Risk, Percentage	17%	20%
Branded Products Segment [Member]
Indefinite-Lived Intangible Assets (Excluding Goodwill)		$ 13,600
Healthcare Apparel Segment [Member]
Indefinite-Lived Intangible Assets (Excluding Goodwill)		14,200
Trade Names 1 [Member]
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		5,581
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 27,760	$ 27,760		$ 33,341

Note 1 - Description of Busin_4

Note 1 - Description of Business, Basis of Presentation and Summary of Accounting Policies - Property, Plant and Equipment (Details)	Dec. 31, 2023
Building [Member] | Minimum [Member]
Property, plant and equipment, useful life (Year)	20 years
Building [Member] | Maximum [Member]
Property, plant and equipment, useful life (Year)	40 years
Building Improvements [Member] | Minimum [Member]
Property, plant and equipment, useful life (Year)	5 years
Building Improvements [Member] | Maximum [Member]
Property, plant and equipment, useful life (Year)	40 years
Machinery, Equipment and Fixtures [Member] | Minimum [Member]
Property, plant and equipment, useful life (Year)	3 years
Machinery, Equipment and Fixtures [Member] | Maximum [Member]
Property, plant and equipment, useful life (Year)	10 years

Note 2 - Allowance for Doubtf_3

Note 2 - Allowance for Doubtful Accounts Receivable - Allowance for Doubtful Accounts Receivable (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balance at the beginning of year	$ 7,622	$ 6,393
Provision for bad debts - accounts receivable	539	2,891
Charge-offs	(3,924)	(1,686)
Recoveries	0	24
Balance at the end of year	$ 4,237	$ 7,622

Note 3 - Reserve for Sales Re_3

Note 3 - Reserve for Sales Returns and Allowance - Reserve for Sales Returns and Allowances (Details) - Allowance For Sales Returns 1 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balance at the beginning of year	$ 2,090	$ 2,636
Provision for returns and allowances	4,678	4,512
Actual returns and allowances paid to customers	(5,360)	(5,058)
Balance at the end of year	$ 1,408	$ 2,090

Note 4 - Inventories - Inventor

Note 4 - Inventories - Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finished goods	$ 72,370	$ 94,228
Work in process	671	401
Raw materials	25,026	30,347
Inventories	$ 98,067	$ 124,976

Note 5 - Property, Plant and _3

Note 5 - Property, Plant and Equipment, Net (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Depreciation, Depletion and Amortization, Nonproduction	$ 13,995	$ 13,004
Property, Plant and Equipment [Member]
Depreciation, Depletion and Amortization, Nonproduction	$ 9,400	$ 7,900

Note 5 - Property, Plant and _4

Note 5 - Property, Plant and Equipment, Net - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, plant and equipment, gross	$ 118,013	$ 122,565
Accumulated depreciation	(71,123)	(71,173)
Property, plant and equipment, net	46,890	51,392
Land [Member]
Property, plant and equipment, gross	2,494	2,494
Buildings Improvements and Leaseholds [Member]
Property, plant and equipment, gross	16,929	18,652
Machinery, Equipment and Fixtures [Member]
Property, plant and equipment, gross	$ 98,590	$ 101,419

Note 6 - Goodwill and Intangi_3

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill, Impairment Loss	$ 0	$ 45,918
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)	0	5,581
Amortization of Intangible Assets	4,600	5,100
Uniforms and Related Products [Member]
Goodwill, Impairment Loss	$ 45,900
Branded Products [Member]
Goodwill, Impairment Loss		25,595
Branded Products [Member] | Trade Names [Member]
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		$ 5,600

Note 6 - Goodwill and Intangi_4

Note 6 - Goodwill and Intangible Assets - Summary of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 01, 2022
Gross goodwill		$ 45,918	$ 39,434
Accumulated impairment losses		(45,918)	0
Net goodwill	$ 0	39,434
Additions		6,463
Impairment charge	0	(45,918)
Foreign currency translation		21
Net goodwill		0
Branded Products [Member]
Gross goodwill		25,595	19,111
Accumulated impairment losses		(25,595)	0
Net goodwill	0	19,111
Additions		6,463
Impairment charge		(25,595)
Foreign currency translation		21
Net goodwill		0
Healthcare Apparel [Member]
Gross goodwill		20,323	20,323
Accumulated impairment losses		(20,323)	$ 0
Net goodwill	$ 0	0
Additions		0
Impairment charge		(20,323)
Foreign currency translation		0
Net goodwill		$ 0

Note 6 - Goodwill and Intangi_5

Note 6 - Goodwill and Intangible Assets - Summary of Indefinite-lived Trade Names (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Indefinite-lived Intangible Assets, impairment charges		$ 0	$ (5,581)
HPI Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		4,700	4,700
Indefinite-lived Intangible Assets, impairment charges			0
Indefinite-lived Intangible Assets, carrying amount		4,700	4,700
BAMKO Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		8,900	8,900
Indefinite-lived Intangible Assets, impairment charges			0
Indefinite-lived Intangible Assets, carrying amount		8,900	8,900
Public Identity Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		0	470
Indefinite-lived Intangible Assets, impairment charges			(470)
Indefinite-lived Intangible Assets, carrying amount		0	0
Tangerine Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		0	3,200
Indefinite-lived Intangible Assets, impairment charges			(3,200)
Indefinite-lived Intangible Assets, carrying amount		0	0
Gifts By Design Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		0	1,170
Indefinite-lived Intangible Assets, impairment charges			(1,170)
Indefinite-lived Intangible Assets, carrying amount		0	0
Sutter's Mill Trade Name [Member] | Branded Products [Member]
Indefinite-lived Intangible Assets, carrying amount		0	741
Indefinite-lived Intangible Assets, impairment charges			(741)
Indefinite-lived Intangible Assets, carrying amount		0	0
CID Resources Trade Name [Member] | Healthcare Apparel [Member]
Indefinite-lived Intangible Assets, carrying amount	[1]	14,160	14,160
Indefinite-lived Intangible Assets, impairment charges	[1]		0
Indefinite-lived Intangible Assets, carrying amount	[1]	14,160	14,160
Trade Names 1 [Member]
Indefinite-lived Intangible Assets, carrying amount		27,760	33,341
Indefinite-lived Intangible Assets, impairment charges			(5,581)
Indefinite-lived Intangible Assets, carrying amount		$ 27,760	$ 27,760
[1]Includes trade names and trademarks associated with CID Resources, Wink™ and Zoey and Chloe.

Note 6 - Goodwill and Intangi_6

Note 6 - Goodwill and Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Definite-lived intangible assets, gross	$ 53,034	$ 52,999
Definite-lived intangible assets, accumulated amortization	(29,634)	(25,006)
Total intangible assets, gross	80,794	80,759
Trade Names 1 [Member]
Trade names	$ 27,760	27,760	$ 33,341
Customer Relationships [Member]
Weighted average life (Year)	11 years 8 months 12 days
Definite-lived intangible assets, gross	$ 50,198	50,198
Definite-lived intangible assets, accumulated amortization	$ (27,417)	(23,330)
Noncompete Agreements [Member]
Weighted average life (Year)	5 years 4 months 24 days
Definite-lived intangible assets, gross	$ 1,712	1,712
Definite-lived intangible assets, accumulated amortization	$ (1,507)	(1,367)
Trademarks [Member]
Weighted average life (Year)	10 years
Definite-lived intangible assets, gross	$ 414	379
Definite-lived intangible assets, accumulated amortization	$ (118)	(72)
Trade Names [Member]
Weighted average life (Year)	2 years
Definite-lived intangible assets, gross	$ 710	710
Definite-lived intangible assets, accumulated amortization	$ (592)	$ (237)

Note 6 - Goodwill and Intangi_7

Note 6 - Goodwill and Intangible Assets - Schedule of Estimated Future Intangible Amortization Expense (Details) $ in Thousands	Dec. 31, 2023 USD ($)
2024	$ 3,719
2025	3,069
2026	3,061
2027	3,020
2028	2,671
Thereafter	7,860
Total	$ 23,400

Note 7 - Other Current Liabil_3

Note 7 - Other Current Liabilities - Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Salaries, wages, commissions and other compensation	$ 14,599	$ 14,316
Contract liabilities	5,346	2,213
Accrued rebates	1,409	2,090
Other accrued expenses	16,639	14,860
Other current liabilities	43,978	38,646
Options Held [Member]
Written put options	1,754	2,032
Other Current Liabilities [Member]
Current operating lease liabilities	$ 4,231	$ 3,135

Note 8 - Long-term Debt (Detail

Note 8 - Long-term Debt (Details Textual) $ in Thousands	Aug. 23, 2022 USD ($)	Dec. 31, 2023 USD ($)
Long-Term Debt, Maturity, Year One		$ 4,688
Long-Term Debt, Maturity, Year Two		5,625
Long-Term Debt, Maturity, Year Three		6,562
Long-Term Debt, Maturity, Year Four		$ 77,500
Credit Agreement [Member]
Debt Instrument Covenant Fixed Charge Coverage Ratio	1.25
Debt Instrument Covenant, Net Leverage Ratio	4
Credit Agreement [Member] | PNC Bank [Member]
Line of Credit Facility, Additional Capacity Available	$ 75,000
Debt, Weighted Average Interest Rate		6.70%
Credit Agreement [Member] | PNC Bank [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	0.10%
Credit Agreement [Member] | PNC Bank [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	0.25%
Credit Agreement [Member] | PNC Bank [Member] | Adjusted Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	1%
Credit Agreement [Member] | PNC Bank [Member] | Adjusted Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	2%
Credit Agreement [Member] | Revolving Credit Facility [Member]
Letters of Credit Outstanding, Amount		$ 0
Credit Agreement [Member] | Revolving Credit Facility [Member] | PNC Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 125,000
Long-Term Debt, Maturity, Year One		4,600
Long-Term Debt, Maturity, Year Two		5,600
Long-Term Debt, Maturity, Year Three		6,600
Long-Term Debt, Maturity, Year Four		$ 52,500
Credit Agreement [Member] | Revolving Credit Facility [Member] | PNC Bank [Member] | Minimum [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.125%
Credit Agreement [Member] | Revolving Credit Facility [Member] | PNC Bank [Member] | Maximum [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.25%
Credit Agreement [Member] | Term Loan [Member] | PNC Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 75,000

Note 8 - Long-term Debt - Long-

Note 8 - Long-term Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Long-term debt, gross	$ 94,375	$ 156,125
Payments due within one year included in current liabilities	4,688	3,750
Debt issuance costs	898	808
Long-term debt less current maturities	88,789	151,567
PNC Bank [Member] | Revolving Credit Facility [Member]
Long-term debt, gross	25,000	83,000
BB&T [Member] | Term Loan Maturing May 2020 [Member]
Long-term debt, gross	$ 69,375	$ 73,125

Note 8 - Long-term Debt - Contr

Note 8 - Long-term Debt - Contractual Maturities of Debt (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Long-Term Debt, Maturity, Year One	$ 4,688
Long-Term Debt, Maturity, Year Two	5,625
Long-Term Debt, Maturity, Year Three	6,562
Long-Term Debt, Maturity, Year Four	77,500
2028	0
Thereafter	0
Total debt	$ 94,375

Note 9 - Income Tax Expense (_3

Note 9 - Income Tax Expense (Benefit) (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 9,769	$ (38,035)
Goodwill and Intangible Asset Impairment		51,500
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	300	200
Other Noncurrent Liabilities [Member]
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 800	$ 800

Note 9 - Income Tax Expense (_4

Note 9 - Income Tax Expense (Benefit) - Schedule of Components of Income (Loss) Before Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Domestic	$ (6,585)	$ (59,407)
Foreign	16,354	21,372
Income (loss) before income tax expense	$ 9,769	$ (38,035)

Note 9 - Income Tax Expense (_5

Note 9 - Income Tax Expense (Benefit)- Income Tax Provisions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Federal	$ 455	$ 3,580
State and local	401	1,314
Foreign	1,776	1,399
Current Income Tax Expense (Benefit)	2,632	6,293
Deferred tax benefit	(1,635)	(12,358)
Income tax expense (benefit)	$ 997	$ (6,065)

Note 9 - Income Tax Expense (_6

Note 9 - Income Tax Expense (Benefit) - Deferred Income Tax Asset (Liability) (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Pension accruals	$ 3,578	$ 3,513
Operating reserves and other accruals	6,613	7,962
Book carrying value in excess of tax basis of intangibles	1,831	2,321
Capitalized research expenses	(2,547)	(1,704)
Disallowed interest	2,167	0
Book carrying value in excess of tax basis of property	(3,950)	(4,183)
Deferred expenses	(430)	(599)
Net deferred income tax asset	$ 12,356	$ 10,718

Note 9 - Income Tax Expense (_7

Note 9 - Income Tax Expense (Benefit) - Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statutory federal income tax rate	21%	21%
State and local income taxes, net of federal income tax benefit	2.50%	3.40%
Rate impacts due to foreign operations	(12.80%)	4.30%
Compensation related	2.10%	(0.80%)
Pension termination	0%	(0.30%)
R&D tax credits	(2.70%)	0.70%
Impairment charge	0%	(11.70%)
Other	0.10%	(0.70%)
Effective income tax rate	10.20%	15.90%

Note 9 - Income Tax Expense (_8

Note 9 - Income Tax Expense (Benefit) - Unrecognized Tax Benefits (Details) - Excluding Interest and Penalties [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balance at the beginning of year	$ 807	$ 801
Additions for tax positions of prior years	105	129
Reductions due to lapse of statute of limitations	(116)	(123)
Balance at the end of year	$ 796	$ 807

Note 10 - Benefit Plans (Detail

Note 10 - Benefit Plans (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Other Assets [Member]
Cash Surrender Value of Life Insurance	$ 9.2	$ 7.7
Other Noncurrent Liabilities [Member]
Deferred Compensation Liability, Classified, Noncurrent	7.9	7.7
Supplemental Employee Retirement Plan [Member]
Defined Benefit Plan, Funded (Unfunded) Status of Plan	(13.6)
Defined Benefit Plan, Expected Amortization, Next Fiscal Year	0.1
Postretirement Life Insurance [Member]
Cash Surrender Value of Life Insurance	4.5	3.9
Gain (Loss) on Investments	$ 0.6	(0.8)
401(K) Plan [Member}
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	25%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0.5	$ 0.6

Note 10 - Benefit Plans - Defin

Note 10 - Benefit Plans - Defined Benefit Plans Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Supplemental Employee Retirement Plan [Member]
Benefit obligation at beginning of year	$ 12,993
Service cost on benefits earned during the period	21	$ 203
Interest cost on projected benefit obligation	637	401
Actuarial (gain) loss	229
Benefits paid	(280)
Benefit obligation at end of year	13,600	12,993
Employer contributions	280
Benefits paid	(280)
Fair value of plan assets at end of year	0
Funded status at end of year	(13,600)
Other current liabilities	(316)
Long-term pension liability	(13,284)
Net amount recognized	(13,600)
Net actuarial loss	1,964
Pension Plan [Member]
Benefit obligation at beginning of year	$ 12,993	15,523
Service cost on benefits earned during the period		203
Interest cost on projected benefit obligation		401
Actuarial (gain) loss		(3,031)
Benefits paid		(103)
Benefit obligation at end of year		12,993
Employer contributions		103
Benefits paid		(103)
Fair value of plan assets at end of year		0
Funded status at end of year		(12,993)
Other current liabilities		(129)
Long-term pension liability		(12,864)
Net amount recognized		(12,993)
Net actuarial loss		$ 1,953

Note 10 - Benefit Plans - Pensi

Note 10 - Benefit Plans - Pension Plans With Projected Benefit Obligation in Excess of Plan Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Pension Plan [Member]
Projected benefit obligation	$ 13,600
Fair value of plan assets	0
Underfunded	$ 13,600
Supplemental Employee Retirement Plan [Member]
Projected benefit obligation		$ 12,993
Fair value of plan assets		0
Underfunded		$ 12,993

Note 10 - Benefit Plans - Net P

Note 10 - Benefit Plans - Net Periodic Benefit Cost (Details) - Supplemental Employee Retirement Plan [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Service cost on benefits earned during the period	$ 21	$ 203
Interest cost on projected benefit obligation	637	401
Recognized actuarial loss	218	1,715
Net periodic pension cost after settlements	$ 876	$ 2,319

Note 10 - Benefit Plans - Assum

Note 10 - Benefit Plans - Assumptions Used to Determine Benefit Obligations and Net Periodic Benefit (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
2022	4.73%	4.93%
2022	3%	3%
2022	4.93%	2.59%
2022	3%	3%

Note 10 - Benefit Plans - Proje

Note 10 - Benefit Plans - Projected Benefit Payments (Details) $ in Thousands	Dec. 31, 2023 USD ($)
2024	$ 4,733
2027	985
2028	975
Pension Plan [Member]
2024	324
2025	1,537
2026	$ 977

Note 11 - Leases (Details Textu

Note 11 - Leases (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Operating Lease, Liability	$ 17,040	$ 7,000
Operating Lease, Liability, Noncurrent	12,809	3,936
Operating Lease, Right-of-Use Asset	17,909	9,113
Prepaid Rent	1,600	2,000
Other Current Liabilities [Member]
Operating Lease, Liability, Current	$ 4,231	$ 3,135
Minimum [Member]
Lessee, Operating Lease, Term of Contract (Year)	1 year
Maximum [Member]
Lessee, Operating Lease, Term of Contract (Year)	8 years

Note 11 - Leases - Lease Cost (

Note 11 - Leases - Lease Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating lease costs	$ 4,495	$ 4,027
Short-term lease costs	609	889
Total lease costs	5,104	4,916
Operating cash flows – cash paid for operating lease liabilities	3,368	2,996
Non-cash – Operating lease right-of-use assets obtained in exchange for new lease liabilities	$ 13,908	$ 4,089
Weighted-average remaining lease term (in years) (Year)	4 years 7 months 6 days	2 years 6 months
Weighted average discount rate	6.57%	5.66%

Note 11 - Leases - Maturities o

Note 11 - Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
2024	$ 4,315
2025	4,243
2026	3,994
2027	3,187
2028	2,811
Thereafter	1,680
Total lease payments	20,230
Less imputed interest	3,190
Present value of lease liabilities	$ 17,040	$ 7,000

Note 12 - Contingencies (Detail

Note 12 - Contingencies (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2022
Business Combination, Contingent Consideration, Liability, Current	$ 1,403			$ 736
Sutter's Mill [Member] | Forecast [Member]
Business Combination, Contingent Consideration, Liability, Current			$ 500
Guardian Products, Inc [Member]
Business Combination, Contingent Consideration, Liability, Current	1,400
Payment for Contingent Consideration Liability, Financing Activities	800
Guardian Products, Inc [Member] | Minimum [Member]
Business Combination, Contingent Consideration, Liability, Current	1,900
Guardian Products, Inc [Member] | Maximum [Member]
Business Combination, Contingent Consideration, Liability, Current	$ 2,200
Guardian Products, Inc [Member] | Forecast [Member]
Business Combination, Contingent Consideration, Liability, Current		$ 900

Note 13 - Share-based Compens_3

Note 13 - Share-based Compensation (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)		2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)	1,262,209
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	5 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value	$ 100	$ 500
Proceeds from Stock Options Exercised	175	728
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 900
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year 2 months 12 days
Stock Appreciation Rights (SARs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 200	100
Employee Service Share-based Compensation, Tax Benefit from Exercise of Equity Instruments Other than Options	0	$ 0
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 200
Restricted Stock [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	1 year 9 months 18 days
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 3,800
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years
Restricted Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	5 years
Performance Shares [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	2 years 3 months 18 days
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 1,100
Performance Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	5 years
Performance Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years
Common Stock [Member]
Shares Received from Stock Options Exercised (in shares)	7,627	9,738
Stock Issued During Period, Shares, New Issues (in shares)	9,115	11,784
Outside Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years

Note 13 - Share-based Compens_4

Note 13 - Share-based Compensation - Shared-based Compensation Expense and the Related Tax Benefit (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-based compensation expense	$ 3,787	$ 4,289
Related income tax benefit	767	804
Stock Options and SARs [Member]
Share-based compensation expense	1,279	1,472
Restricted Stock [Member]
Share-based compensation expense	2,560	2,598
Performance Shares [Member]
Share-based compensation expense	$ (52)	$ 219

Note 13 - Share-based Compens_5

Note 13 - Share-based Compensation - Summary of Significant Assumptions for Share-based Compensation Awards (Details) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Option [Member]
Weighted average fair value per share at grant date (in dollars per share)	$ 4.14	$ 5.39
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Risk free interest rate	3.50%	1.60%
Expected award life (years) (Year)	3 years	3 years
Expected volatility	46.90%	46.80%
Expected dividend yield	4.70%	2.40%
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Risk free interest rate	4.90%	3.80%
Expected award life (years) (Year)	10 years	10 years
Expected volatility	67.80%	65%
Expected dividend yield	7.10%	5.60%
Stock Appreciation Rights (SARs) [Member]
Risk free interest rate	4%
Expected award life (years) (Year)	3 years
Expected volatility	67.80%
Expected dividend yield	4.70%
Weighted average fair value per share at grant date (in dollars per share)	$ 4.58	$ 6.34
Stock Appreciation Rights (SARs) [Member] | Minimum [Member]
Risk free interest rate		1.60%
Expected award life (years) (Year)		3 years
Expected volatility		61.60%
Expected dividend yield		2.40%
Stock Appreciation Rights (SARs) [Member] | Maximum [Member]
Risk free interest rate		3.80%
Expected award life (years) (Year)		4 years
Expected volatility		64.80%
Expected dividend yield		5.60%

Note 13 - Share-based Compens_6

Note 13 - Share-based Compensation - Stock Option Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Outstanding, options (in shares)	962,775
Outstanding, weighted average exercise price (in dollars per share)	$ 15.89
Outstanding, weighted average remaining life (Year)	2 years 9 months 18 days	3 years 3 months 3 days
Outstanding, aggregate intrinsic value	$ 1,718	$ 301
Granted (in shares)	200,091
Granted, weighted average exercise price (in dollars per share)	$ 11.37
Exercised (in shares)	(28,728)
Exercised, weighted average exercise price (in dollars per share)	$ 9.55
Lapsed or cancelled (in shares)	(180,962)
Lapsed or cancelled, weighted average exercise price (in dollars per share)	$ 17.99
Outstanding, options (in shares)	953,176	962,775
Outstanding, weighted average exercise price (in dollars per share)	$ 14.73	$ 15.89
Exercisable, options (in shares)	501,610
Exercisable, weighted average exercise price, options (in dollars per share)	$ 16.18
Exercisable, weighted average remaining life (Year)	1 year 7 months 17 days
Exercisable, aggregate intrinsic value, options	$ 813

Note 13 - Share-based Compens_7

Note 13 - Share-based Compensation - Stock-settled Stock Appreciation Rights Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Lapsed or cancelled (in shares)	(180,962)
Lapsed or cancelled, weighted average exercise price (in dollars per share)	$ 17.99
Stock Appreciation Rights (SARs) [Member]
Outstanding SARS (in shares)	320,385
Outstanding (in dollars per share)	$ 15.23
Outstanding SARS, weighted average remaining life (Year)	2 years 25 days	2 years 2 months 23 days
Outstanding SARS, aggregate intrinsic value	$ 506	$ 69
Granted SARs (in shares)	51,209
Granted SARS, weighted average exercise price (in dollars per share)	$ 12.04
Exercised SARs (in shares)	(41,226)
Exercised SARS, weighted average exercise price (in dollars per share)	$ 9.83
Lapsed or cancelled (in shares)	(37,860)
Lapsed or cancelled, weighted average exercise price (in dollars per share)	$ 23.62
Outstanding SARS (in shares)	292,508	320,385
Outstanding SARS, weighted average exercise price (in dollars per share)	$ 14.35	$ 15.23
Exercisable (in shares)	184,245
Exercisable, weighted average exercise price (in dollars per share)	$ 14.29
Exercisable SARS, weighted average remaining life (Year)	1 year 1 month 6 days
Exercisable, aggregate intrinsic value	$ 361

Note 13 - Share-based Compens_8

Note 13 - Share-based Compensation - Restricted Stock Transactions (Details) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Outstanding (in shares) | shares	372,470
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.45
Granted (in shares) | shares	155,213
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 11.53
Vested (in shares) | shares	(99,317)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 16.46
Forfeited (in shares) | shares	0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Outstanding (in shares) | shares	428,366
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 18.14

Note 13 - Share-based Compens_9

Note 13 - Share-based Compensation - Performance Share Transactions (Details) - Performance Shares [Member]	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Outstanding (in shares) | shares	199,451
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.57
Granted (in shares) | shares	94,028
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 12.56
Vested (in shares) | shares	(4,558)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.54
Forfeited (in shares) | shares	(5,400)
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	$ 9.48
Outstanding (in shares) | shares	283,521
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 18.13

Note 14 - Net Income (Loss) P_3

Note 14 - Net Income (Loss) Per Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded From Computation Of Earnings Weighted Average Shares Outstanding (in shares)		400,381
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,113,935	687,117
Antidilutive Securities Excluded from Computation of Earnings Per Share, Weight Average Exercise Price (in dollars per share)	$ 15.95	$ 21.06

Note 14 - Net Income (Loss) P_4

Note 14 - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Net income (loss)	$ 8,772	$ (31,970)
Weighted average shares outstanding - basic (in shares)	15,968,199	15,764,859
Dilutive common stock equivalents (in shares)	191,109	0
Weighted average shares outstanding - diluted (in shares)	16,159,308	15,764,859
Basic (in dollars per share)	$ 0.55	$ (2.03)
Diluted (in dollars per share)	$ 0.54	$ (2.03)

Note 15 - Net Sales (Details Te

Note 15 - Net Sales (Details Textual) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Contract with Customer, Liability, Revenue Recognized	$ 2.2

Note 15 - Net Sales - Disaggreg

Note 15 - Net Sales - Disaggregated Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Net sales	$ 543,302	$ 578,831
Intersegment Eliminations [Member]
Net sales	(4,756)	(6,639)
Branded Products Segment [Member]
Net sales	342,680	387,931
Branded Products Segment [Member] | Branded Products [Member]
Net sales	342,456	381,363
Branded Products Segment [Member] | Protective Equipment [Member]
Net sales	224	6,568
Healthcare Apparel Segment [Member]
Net sales	113,878	113,321
Healthcare Apparel Segment [Member] | Protective Equipment [Member]
Net sales	3,007	2,816
Healthcare Apparel Segment [Member] | Healthcare Apparel [Member]
Net sales	110,871	110,505
Contact Centers Segment [Member]
Net sales	86,744	77,579
Contact Centers Segment [Member] | Intersegment Eliminations [Member]
Net sales	(4,756)	(6,639)
Contact Centers Segment [Member] | Contact Centers [Member]
Net sales	$ 91,500	$ 84,218

Note 15 - Net Sales - Accounts

Note 15 - Net Sales - Accounts Receivable and Contract Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accounts receivable	$ 103,494	$ 104,813
Current contract assets	48,715	52,980
Current contract liabilities	$ 5,346	$ 2,213

Note 16 - Stock Repurchase Pl_2

Note 16 - Stock Repurchase Plan (Details Textual) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	May 02, 2019
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased (in shares)	657,451		750,000
Stock Repurchased and Retired During Period, Shares (in shares)	0	0

Note 17 - Operating Segment I_3

Note 17 - Operating Segment Information - Information Related to the Operations of the Company's Operating Segments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Net sales	$ 543,302	$ 578,831
Segment Adjusted EBITDA	33,482	27,927
Depreciation and amortization	13,995	13,004
Capital expenditures	4,963	11,018
Total assets	422,450	456,941
Depreciation, Depletion and Amortization, Nonproduction	13,995	13,004
Operating Segments [Member] | Branded Products [Member]
Net sales	342,680	387,931
Segment Adjusted EBITDA	33,146	31,144
Depreciation and amortization	6,744	6,465
Capital expenditures	2,550	4,643
Total assets	218,018	224,116
Depreciation, Depletion and Amortization, Nonproduction	6,744	6,465
Operating Segments [Member] | Healthcare Apparel [Member]
Net sales	113,878	113,321
Segment Adjusted EBITDA	7,997	(2,747)
Depreciation and amortization	3,925	3,946
Capital expenditures	960	1,169
Total assets	131,168	150,335
Depreciation, Depletion and Amortization, Nonproduction	3,925	3,946
Operating Segments [Member] | Contact Centers [Member]
Net sales	91,500	84,218
Segment Adjusted EBITDA	12,408	18,521
Depreciation and amortization	2,942	2,373
Capital expenditures	1,392	4,876
Total assets	40,941	43,368
Depreciation, Depletion and Amortization, Nonproduction	2,942	2,373
Intersegment Eliminations [Member]
Net sales	(4,756)	(6,639)
Segment Adjusted EBITDA	0	0
Depreciation and amortization	0	0
Capital expenditures	0	0
Total assets	0	0
Depreciation, Depletion and Amortization, Nonproduction	0	0
Segment Reconciling Items [Member]
Net sales	0	0
Segment Adjusted EBITDA	(20,069)	(18,991)
Depreciation and amortization	384	220
Capital expenditures	61	330
Total assets	32,323	39,122
Depreciation, Depletion and Amortization, Nonproduction	$ 384	$ 220

Note 17 - Operating Segment I_4

Note 17 - Operating Segment Information - Segment Adjusted EBITDA Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income (loss) before income tax expense	$ 9,769	$ (38,035)
Interest expense	9,718	4,894
Depreciation and amortization	13,995	13,004
Goodwill impairment charge	0	45,918
Intangible assets impairment charge	0	5,581
Gain on sale of property, plant and equipment	0	(3,435)
Segment Adjusted EBITDA	$ 33,482	$ 27,927

Note 18 - Acquisition of Busi_3

Note 18 - Acquisition of Businesses (Details Textual) - USD ($) $ in Thousands		12 Months Ended
	May 01, 2022	Dec. 31, 2023
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		11 years 8 months 12 days
Noncompete Agreements [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		5 years 4 months 24 days
Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		2 years
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		3 years
Guardian Products, Inc [Member]
Payments to Acquire Businesses, Gross	$ 11,077
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	2,300
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	5,886
Guardian Products, Inc [Member] | Customer Relationships [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 5,000
Finite-Lived Intangible Asset, Useful Life (Year)	7 years
Guardian Products, Inc [Member] | Noncompete Agreements [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 200
Finite-Lived Intangible Asset, Useful Life (Year)	5 years
Guardian Products, Inc [Member] | Trade Names [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 700
Finite-Lived Intangible Asset, Useful Life (Year)	2 years
Guardian Products, Inc [Member] | Restricted Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	116,550
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years

Note 18 - Acquisition of Busi_4

Note 18 - Acquisition of Businesses - Purchase Price (Details) - Guardian Products, Inc [Member] $ in Thousands	May 01, 2022 USD ($)
Cash consideration	$ 11,077
Restricted shares of Superior common stock issued	2,000
Contingent consideration	1,119
Total Consideration	$ 14,196

Note 18 - Acquisition of Busi_5

Note 18 - Acquisition of Businesses - Aggregate Consideration (Details) - USD ($) $ in Thousands	Dec. 31, 2022	May 01, 2022	Dec. 31, 2021
Goodwill	$ 0		$ 39,434
Guardian Products, Inc [Member]
Accounts receivable		$ 1,656
Inventories		621
Prepaid expenses and other current assets		272
Property, plant and equipment		15
Intangible assets		5,886
Goodwill		6,463
Total assets		14,913
Accounts payable		533
Other current liabilities		184
Total liabilities		$ 717